[go: up one dir, main page]

HK1221137B - Diabetes management system with a medical device - Google Patents

Diabetes management system with a medical device Download PDF

Info

Publication number
HK1221137B
HK1221137B HK16109332.0A HK16109332A HK1221137B HK 1221137 B HK1221137 B HK 1221137B HK 16109332 A HK16109332 A HK 16109332A HK 1221137 B HK1221137 B HK 1221137B
Authority
HK
Hong Kong
Prior art keywords
data
patient
diabetes management
management system
portable medical
Prior art date
Application number
HK16109332.0A
Other languages
Chinese (zh)
Other versions
HK1221137A1 (en
Inventor
Eric CARLSGAARD
Igor Gejdos
David M. KEPLEY
Christian LINDMAYER
Michael Lee Long
Angela S. MC DANIEL
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/245,180 external-priority patent/US20140324445A1/en
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of HK1221137A1 publication Critical patent/HK1221137A1/en
Publication of HK1221137B publication Critical patent/HK1221137B/en

Links

Description

具有医学设备的糖尿病管理系统Diabetes management system with medical devices

技术领域Technical Field

本公开涉及设备设置的使用、医学和使用数据以及利用用于患有糖尿病的患者的管理系统的统计学。The present disclosure relates to the use of device settings, medical and usage data, and statistics utilizing a management system for patients with diabetes.

背景技术Background Art

本章节提供并不必然是现有技术的涉及本公开的背景信息。This section provides background information related to the present disclosure which is not necessarily prior art.

患有糖尿病的人员具有调整其身体中的血糖水平的困难。作为结果,这些人员中的许多人携带专用便携式医学设备(诸如血糖仪),其允许他们定期测量其葡萄糖水平并且采取包括派给胰岛素的适当行动。在取得血糖测量或测量系列之后,糖尿病患者可能发现将这些测量传送给他或她的保健专业人员以供进一步考查和分析是有用的。在这方面,患者的血糖仪可以能够存储血糖测量以供患者或保健专业人员稍后考查和分析,患者或保健专业人员然后可以手动或电子地记录测量。People with diabetes have difficulty regulating their blood glucose levels. As a result, many of these people carry specialized portable medical devices (such as blood glucose meters) that allow them to regularly measure their glucose levels and take appropriate action, including administering insulin. After taking a blood glucose measurement or series of measurements, a diabetic patient may find it useful to transmit these measurements to their healthcare professional for further review and analysis. In this regard, a patient's blood glucose meter may be capable of storing blood glucose measurements for later review and analysis by the patient or healthcare professional, who can then record the measurements manually or electronically.

测量、存储、记录和分析血糖水平的过程对于患者和患者的保健专业人员二者而言可能是非常耗时的过程。数据的交换和考查可能要求患者与保健专业人员之间的会面。患有糖尿病的人通常在搜索更好且更高效的方式来管理其健康。此外,保健专业人员需要新的方式来激励患有糖尿病的人更有效地进行通信。技术可以提供用于针对各种各样的消费者要求的软件应用的可行平台。而且,许多患有糖尿病的人在其日常生活中使用个人计算机和/或移动设备。The process of measuring, storing, recording and analyzing blood glucose levels can be a very time-consuming process for both the patient and the patient's healthcare professional. The exchange and review of data may require a meeting between the patient and the healthcare professional. People with diabetes are generally searching for better and more efficient ways to manage their health. In addition, healthcare professionals need new ways to encourage people with diabetes to communicate more effectively. Technology can provide a feasible platform for software applications for a variety of consumer requirements. Moreover, many people with diabetes use personal computers and/or mobile devices in their daily lives.

发明内容Summary of the Invention

本申请要求享有2013年4月26日提交的美国临时申请No.61/816,642和61/816,659的权益。以上申请中的每一个的全部公开内容通过引用并入本文。This application claims the benefit of U.S. Provisional Application Nos. 61/816,642 and 61/816,659, filed April 26, 2013. The entire disclosure of each of the above applications is incorporated herein by reference.

本章节提供公开内容的一般概述,并且不是其完整范围或其全部特征的全面公开。This section provides a general summary of the disclosure, and is not a comprehensive disclosure of its full scope or all of its features.

本发明的目的是提供如独立权利要求中所指定的改进的糖尿病管理系统和对应的方法。在相应从属权利要求中给出各种实施例和对此的增强。在以下段落中描述的实施例和特征可以与彼此自由地组合,如果它们不相互排斥的话。The object of the present invention is to provide an improved diabetes management system and a corresponding method as specified in the independent claims. Various embodiments and enhancements thereto are given in the corresponding dependent claims. The embodiments and features described in the following paragraphs can be freely combined with one another, if they are not mutually exclusive.

在一方面中,本发明涉及用于监视多次皮下注射胰岛素治疗的糖尿病管理系统。系统包括与患者相关联的便携式医学设备和由患者和保健提供者二者可访问的数据储存库。系统还包括糖尿病管理应用,其被配置用于从便携式医学设备接收数据并且将其存储在数据储存库中。数据可以包括与患者相关联的医学数据和与患者对便携式医学设备的使用相关联的使用数据。糖尿病管理应用可以配置成累积和评估涉及医学数据或使用数据的统计量,并且当统计量满足或超过预确定的治疗准则时向患者或保健提供者提供治疗推荐。In one aspect, the present invention relates to a diabetes management system for monitoring multiple subcutaneous insulin therapy. The system includes a portable medical device associated with a patient and a data repository accessible to both the patient and a healthcare provider. The system also includes a diabetes management application configured to receive data from the portable medical device and store it in the data repository. The data may include medical data associated with the patient and usage data associated with the patient's use of the portable medical device. The diabetes management application may be configured to accumulate and evaluate statistics related to the medical data or usage data and provide treatment recommendations to the patient or healthcare provider when the statistics meet or exceed predetermined treatment criteria.

所述特征可以改进存储、传送和分析血糖测量的有效性和效率。可以使得患者和患者的保健专业人员能够向集中式电子数据储存库发送包括血糖测量的数据以供稍后检索和分析。这可以帮助改进糖尿病的管理和治疗。所述特征还可以帮助确保服从治疗疗程并且改进血糖控制。收集和统计评估涉及患者依循性的使用数据可以帮助考查和监视患者和/或负责的保健提供者对治疗疗程依循性。The features described herein can improve the effectiveness and efficiency of storing, transmitting, and analyzing blood glucose measurements. Patients and their healthcare professionals can be enabled to send data, including blood glucose measurements, to a centralized electronic data repository for later retrieval and analysis. This can help improve the management and treatment of diabetes. The features described herein can also help ensure adherence to treatment regimens and improve glycemic control. Collecting and statistically evaluating usage data related to patient compliance can help assess and monitor patient and/or responsible healthcare provider adherence to treatment regimens.

在另外的方面,本教导提供一种用于共享信息和管理具有医学条件的患者的诊断和治疗的方法。方法包括在一个或多个服务器处提供患者和保健提供者二者可访问的web门户账户。web门户账户可以与便携式医学设备相关联。方法包括在一个或多个服务器处从便携式医学设备接收医学数据和使用数据;医学数据可以与患者相关联并且使用数据可以与患者对医学设备的使用相关联。涉及医学数据或使用数据的统计量在一个或多个服务器处累积。统计量可以在一段时间内累积并且可以在web门户账户中可访问。方法包括在一个或多个服务器处与治疗准则有关地评估统计量;以及当至少一个统计量满足或超过预确定的治疗准则时从一个或多个服务器向患者或保健提供者发送治疗推荐。In another aspect, the present teachings provide a method for sharing information and managing diagnosis and treatment of patients with medical conditions. The method includes providing a web portal account accessible to both the patient and the healthcare provider at one or more servers. The web portal account can be associated with a portable medical device. The method includes receiving medical data and usage data from the portable medical device at one or more servers; the medical data can be associated with the patient and the usage data can be associated with the patient's use of the medical device. Statistics related to the medical data or usage data are accumulated at one or more servers. The statistics can be accumulated over a period of time and can be accessed in the web portal account. The method includes evaluating the statistics in relation to treatment criteria at one or more servers; and sending a treatment recommendation from the one or more servers to the patient or the healthcare provider when at least one statistic meets or exceeds a predetermined treatment criterion.

根据实施例,患者参与作为糖尿病治疗的部分的多次皮下注射胰岛素疗程。According to an embodiment, a patient is taking a course of multiple subcutaneous insulin injections as part of diabetes treatment.

根据实施例,统计量指示血糖测量、碳水化合物消耗、用药治疗、基础率和对治疗推荐的依循性中的至少一个。According to an embodiment, the statistic is indicative of at least one of blood glucose measurement, carbohydrate consumption, medication therapy, basal rate, and compliance with treatment recommendations.

根据实施例,方法还包括从与患者相关联的多个便携式医学设备累积统计量。According to an embodiment, the method further comprises accumulating statistics from a plurality of portable medical devices associated with the patient.

根据实施例,方法还包括基于治疗推荐从一个或多个服务器远程调节便携式医学设备上的至少一个设备设置。According to an embodiment, the method further comprises remotely adjusting, from the one or more servers, at least one device setting on the portable medical device based on the treatment recommendation.

根据实施例,设备设置包括胰岛素:碳水化合物比、基础率、最大用药量、校准设置、实用程序设置和警报设置中的至少一个。According to an embodiment, the device settings include at least one of an insulin:carbohydrate ratio, a basal rate, a maximum dosage, a calibration setting, a utility setting, and an alarm setting.

根据实施例,使用数据包括指示患者对用药治疗建议的依循性的数据。According to an embodiment, the usage data includes data indicative of the patient's compliance with medication therapy recommendations.

根据实施例,治疗推荐作为电子消息发送到便携式医学设备。According to an embodiment, the treatment recommendation is sent as an electronic message to the portable medical device.

根据实施例,方法还包括在向患者发送治疗推荐之前征求来自保健提供者的输入。According to an embodiment, the method further comprises soliciting input from a healthcare provider before sending the treatment recommendation to the patient.

根据实施例,方法还包括向保健提供者提供一个或多个所提出的治疗推荐,其中保健提供者选择至少一个所提出的治疗推荐以用于发送给患者。According to an embodiment, the method further includes providing one or more proposed treatment recommendations to a healthcare provider, wherein the healthcare provider selects at least one proposed treatment recommendation for sending to the patient.

根据实施例,治疗推荐包括关于饮食习惯的提醒、从便携式医学设备向web门户账户转移数据的提醒、测试血糖水平的提醒、校正基础率改变推荐和校正用药剂量推荐中的至少一个。According to an embodiment, the treatment recommendation includes at least one of a reminder regarding eating habits, a reminder to transfer data from the portable medical device to the web portal account, a reminder to test blood glucose levels, a correction basal rate change recommendation, and a correction medication dosage recommendation.

根据实施例,与web门户账户相关联的数据经由便携式医学设备可访问。According to an embodiment, data associated with the web portal account is accessible via the portable medical device.

在其他方面中,本教导提供一种用于参与多次皮下注射胰岛素疗程的患者的糖尿病管理和治疗的方法。方法包括在一个或多个服务器处提供患者和保健提供者二者可访问的web门户账户。web门户账户可以与便携式医学设备相关联。在一个或多个服务器处从便携式医学设备接收医学数据和使用数据。医学数据可以与患者相关联并且使用数据可以与患者对便携式医学设备的使用相关联。方法包括在一个或多个服务器处累积涉及医学数据或使用数据的统计量。统计量可以在一段时间内累积并且在web门户账户中可访问。统计量与治疗准则有关地在一个或多个服务器处评估并且可以与web门户账户相关联以供患者和保健提供者中的一个或二者访问。方法包括当至少一个统计量满足或超过预确定的治疗准则时向患者或保健提供者提供治疗推荐。In other aspects, the present teachings provide a method for managing and treating diabetes in a patient who is participating in a course of multiple subcutaneous insulin injections. The method includes providing a web portal account accessible to both the patient and the healthcare provider at one or more servers. The web portal account can be associated with a portable medical device. Medical data and usage data are received from the portable medical device at one or more servers. The medical data can be associated with the patient and the usage data can be associated with the patient's use of the portable medical device. The method includes accumulating statistics related to the medical data or usage data at one or more servers. The statistics can be accumulated over a period of time and accessible in the web portal account. The statistics are evaluated at one or more servers in relation to treatment criteria and can be associated with the web portal account for access by one or both of the patient and the healthcare provider. The method includes providing a treatment recommendation to the patient or the healthcare provider when at least one statistic meets or exceeds a predetermined treatment criterion.

根据实施例,提供web门户账户、接收医学数据和使用数据、累积涉及医学数据或使用数据的统计量、评估统计量和向患者或保健提供者提供治疗推荐的步骤可以由一个或多个服务器的相同集合施行。According to an embodiment, the steps of providing a web portal account, receiving medical data and usage data, accumulating statistics related to the medical data or usage data, evaluating the statistics, and providing treatment recommendations to the patient or healthcare provider may be performed by the same set of one or more servers.

根据实施例,治疗推荐包括调节患者的胰岛素:碳水化合物比。According to an embodiment, the treatment recommendation includes adjusting the patient's insulin:carbohydrate ratio.

根据实施例,方法还包括从一个或多个服务器向便携式医学设备发送作为电子消息的治疗推荐。According to an embodiment, the method further comprises sending the treatment recommendation as an electronic message from the one or more servers to the portable medical device.

根据实施例,方法还包括基于治疗推荐从一个或多个服务器远程调节便携式医学设备上的至少一个设备设置。According to an embodiment, the method further comprises remotely adjusting, from the one or more servers, at least one device setting on the portable medical device based on the treatment recommendation.

根据实施例,设备设置包括胰岛素:碳水化合物比、基础率、最大用药量、校准设置、实用程序设置和警报设置中的至少一个。According to an embodiment, the device settings include at least one of an insulin:carbohydrate ratio, a basal rate, a maximum dosage, a calibration setting, a utility setting, and an alarm setting.

根据实施例,保健提供者选择统计量以供评估。According to an embodiment, a healthcare provider selects a statistic for evaluation.

根据实施例,以上描述的实施例中的任何一个的方法由一个或多个计算机(例如一个或多个服务器)实现和施行。According to an embodiment, the method of any one of the above-described embodiments is implemented and executed by one or more computers (eg, one or more servers).

另外的适用性领域将从本文所提供的描述变得显而易见。在本概述中的描述和具体示例仅意图用于说明的目的并且不意图限制本公开的范围。Further areas of applicability will become apparent from the description provided herein.The description and specific examples in this summary are intended for purposes of illustration only and are not intended to limit the scope of the present disclosure.

附图说明BRIEF DESCRIPTION OF THE DRAWINGS

本文所描述的附图仅仅用于说明所选实施例而非所有可能实现的目的,并且不意图限制本公开的范围。The drawings described herein are for illustrative purposes only of selected embodiments and not all possible implementations, and are not intended to limit the scope of the present disclosure.

图1是描绘示例性糖尿病管理系统的图;FIG1 is a diagram depicting an exemplary diabetes management system;

图2是描绘用于糖尿病管理系统的软件架构系统的图;FIG2 is a diagram depicting a software architecture system for a diabetes management system;

图3是描绘糖尿病管理系统的可替换实施例的图;FIG3 is a diagram depicting an alternative embodiment of a diabetes management system;

图4是描绘用于图3中所示的糖尿病管理系统的软件架构系统的可替换实施例的图;FIG4 is a diagram depicting an alternative embodiment of a software architecture system for the diabetes management system shown in FIG3 ;

图5是描绘用于图3中所示的糖尿病管理系统的软件架构系统的又一可替换实施例的图;FIG5 is a diagram depicting yet another alternative embodiment of a software architecture system for the diabetes management system shown in FIG3 ;

图6是图示了共享信息和管理具有医学条件的患者的诊断的方法的一个实施例的流程图;6 is a flow chart illustrating one embodiment of a method of sharing information and managing diagnoses for patients having medical conditions;

图7-13图示了可以与糖尿病管理系统、管理应用、web浏览器、web门户账户和有关软件架构一起使用的各种图形用户接口;以及7-13 illustrate various graphical user interfaces that may be used with the diabetes management system, management application, web browser, web portal account, and related software architecture; and

图14是描绘糖尿病管理系统的实施例的操作的图。14 is a diagram depicting the operation of an embodiment of a diabetes management system.

对应参考标号遍及附图的若干视图指示对应部分。Corresponding reference numerals indicate corresponding parts throughout the several views of the drawings.

具体实施方式DETAILED DESCRIPTION

现在将参照附图更加完整地描述示例实施例。Example embodiments will now be described more fully with reference to the accompanying drawings.

虽然胰岛素泵的使用是可管理的以用于许多患有糖尿病的患者,但是其他患者决定使用多次皮下注射疗程(MDI),其可以允许生活方式中的更多变化。然而,伴随着生活方式中的变化,患者必须认识到小心监视其糖尿病疗程,并且主动进行血糖测试和胰岛素派给。本公开提供了用于改进的糖尿病管理的系统和方法,包括检测、标识和补救其中患有糖尿病的患者从规定疗法偏离的某些情形的能力。在各种方面中,当检测到、评估到或以其他方式从便携式医学设备的设置和/或涉及医学数据和使用数据或者从其获得的统计量标识出不一致或不符,本文所提供的系统和方法能够帮助提供各种治疗推荐。帮助可以包括评估医学数据、使用数据和设备设置,以及确定供患者或保健提供者考虑的一个或多个适当的治疗推荐。While the use of an insulin pump is manageable for many patients with diabetes, other patients decide to use a course of multiple subcutaneous injections (MDIs), which can allow for more changes in lifestyle. However, along with changes in lifestyle, patients must be aware of the importance of carefully monitoring their diabetes regimen and proactively performing blood glucose testing and insulin administration. The present disclosure provides systems and methods for improved diabetes management, including the ability to detect, identify, and remedy certain situations in which patients with diabetes deviate from prescribed therapy. In various aspects, when inconsistencies or discrepancies are detected, assessed, or otherwise identified from the settings of a portable medical device and/or related medical data and usage data or statistics obtained therefrom, the systems and methods provided herein can help provide various treatment recommendations. The assistance can include evaluating the medical data, usage data, and device settings, and determining one or more appropriate treatment recommendations for consideration by the patient or healthcare provider.

在各种方面中,糖尿病管理系统可以提供包括用于便携式医学设备的设置改变、胰岛素派给中的改变以及血糖测试、提醒、警报或甚至基于依循性因素的激励语句的治疗推荐,其具有增加对治疗疗程的遵从性并且最终提供改进的血糖控制的目标。In various aspects, the diabetes management system can provide treatment recommendations that include setting changes for portable medical devices, changes in insulin dosing and blood glucose testing, reminders, alarms, or even motivational statements based on compliance factors, with the goal of increasing compliance with the treatment regimen and ultimately providing improved glycemic control.

疗程依循性问题对于患有糖尿病的某些个人可能是常见的,这通常使血糖控制难以实现。由于可以通过正确依循性来降低糖尿病并发症的风险,因此患者未依循治疗推荐对于糖尿病患者及其保健专业人员二者而言可能是令人沮丧的。研究已经显示出,对于慢性病疗程和对于生活方式改变的依循率大致为大约50%。根据本公开的糖尿病管理系统的各种实现,涉及患者依循性的使用数据可以通过统计分析来收集和评估以供患者和保健提供者考查和监视。涉及依循性的使用数据可以包括例如在指定周期期间进行的血糖测量的数目和计时;所派给的用药治疗的数目、量和计时;所派给的校正治疗的数目、量和计时;记录就餐数据和碳水化物信息、锻炼惯例、数据上传、疾病、进行规定的药品或医学治疗、参加医学会面、行为改变等。Treatment adherence issues can be common for some individuals with diabetes, which often makes glycemic control difficult to achieve. Because the risk of diabetic complications can be reduced through proper adherence, patient failure to adhere to treatment recommendations can be frustrating for both diabetic patients and their healthcare professionals. Studies have shown that adherence rates for chronic disease treatments and for lifestyle changes are roughly around 50%. According to various implementations of the diabetes management system of the present disclosure, usage data related to patient adherence can be collected and evaluated through statistical analysis for review and monitoring by patients and healthcare providers. Usage data related to adherence can include, for example, the number and timing of blood glucose measurements taken during a specified period; the number, amount, and timing of medications administered; the number, amount, and timing of corrective treatments administered; recording of meal data and carbohydrate information, exercise routines, data uploads, illnesses, taking prescribed medications or medical treatments, attending medical appointments, behavioral changes, etc.

对于具有MDI基本用药糖尿病治疗疗程的患者,基本和用药治疗应当小心配置和监视。基础率确定和校正可以基于各个患者要求和改变周期而变化。例如,可能影响基础率的因素可以包括生长陡增、增重或减重、新的或修改的药物治疗、荷尔蒙改变、进食改变和延长的禁食、睡眠改变、锻炼惯例改变、长时间不活动、疾病、压力和季节改变。关于用药胰岛素派给,碳水化合物计数和胰岛素与碳水化合物比是匹配胰岛素和食物的两个重要工具。为了正确用药,糖尿病患者将需要计算每一餐中碳水化合物的近似数目,并且知晓他或她的胰岛素与碳水化合物比。便携式医学设备可以预编程有患者的特定比,其可以按需调节。胰岛素:碳水化合物比可以用于计算用于每一餐和/或零食的胰岛素的用药剂量。For patients with MDI basic medication diabetes treatment course, basic and medication treatment should be carefully configured and monitored. Basal rate determination and correction can change based on individual patient requirements and change cycle. For example, the factors that may affect basal rate can include growth spurt, weight gain or weight loss, new or revised medication, hormonal changes, changes in eating and prolonged fasting, sleep changes, exercise routine changes, long-term inactivity, disease, stress and seasonal changes. About medication insulin dispatch, carbohydrate counting and insulin to carbohydrate ratio are two important tools for matching insulin and food. For correct medication, diabetic patients will need to calculate the approximate number of carbohydrates in each meal, and know his or her insulin to carbohydrate ratio. Portable medical equipment can be pre-programmed with the patient's specific ratio, which can be adjusted as needed. Insulin: carbohydrate ratio can be used to calculate the dosage of insulin for each meal and/or snacks.

作为示例,具有1:5的胰岛素:碳水化合物比的糖尿病疗程的人员将会取5单位的速效胰岛素作为用药治疗以覆盖包含50g碳水化合物的餐食,除了其基本胰岛素之外。该计算通常可以在尝试与错误的基础上确定,并且对于具有严重胰岛素抗性的2型糖尿病,数目可以高得多。标准比可以是1:15。通过考查针对给定患者的统计量和历史数据,保健提供者可以能够提供涉及该比的更新的治疗推荐。在一个示例中,保健提供者可以看向胰岛素:碳水化合物比并且看到其在历史上被设置在1:20处。在另一示例中,患者可以在就餐之前例行地具有范围内的血糖水平,但是在餐后大约2-3小时的时候,血糖水平保持为高。这可以是另一示例,其中减小胰岛素:碳水化合物比可以是有益的。如果患者的血糖水平一贯不适宜,保健提供者可以能够使用本技术的web门户并且看向统计量、使用数据、设备设置和诸如锻炼、食物摄入以及依循性数据之类的其他因素,并且最终查明患者并未得到针对其摄入的碳水化合物的足够胰岛素。保健提供者然后可以例如提供将比调节到1:15的治疗推荐,以补偿血糖水平。在某些方面中,web门户能够与本文所公开的糖尿病管理系统协作以提供涉及对保健提供者而言感兴趣的因素的所收集的统计量,诸如患者锻炼惯例、食物摄入和使用/依循性数据。各种数据可以由患者上传到web门户和糖尿病管理系统。As an example, a person on a diabetes regimen with an insulin:carbohydrate ratio of 1:5 would take 5 units of rapid-acting insulin as medication to cover a meal containing 50g of carbohydrates, in addition to their basal insulin. This calculation can typically be determined on a trial-and-error basis, and for type 2 diabetics with severe insulin resistance, the number can be much higher. A standard ratio might be 1:15. By examining statistics and historical data for a given patient, a healthcare provider can provide updated treatment recommendations related to this ratio. In one example, a healthcare provider can look at the insulin:carbohydrate ratio and see that it has historically been set at 1:20. In another example, a patient may routinely have a blood sugar level within range before a meal, but approximately 2-3 hours after the meal, the blood sugar level remains high. This could be another example where reducing the insulin:carbohydrate ratio could be beneficial. If a patient's blood sugar levels are consistently unacceptable, a healthcare provider can use the web portal of the present technology and look at statistics, usage data, device settings, and other factors such as exercise, food intake, and compliance data to ultimately determine that the patient is not receiving enough insulin for the carbohydrates they consume. The healthcare provider can then provide a treatment recommendation, for example, to adjust the ratio to 1:15 to compensate for the blood glucose level. In certain aspects, the web portal can collaborate with the diabetes management system disclosed herein to provide collected statistics related to factors of interest to healthcare providers, such as patient exercise routines, food intake, and usage/adherence data. Various data can be uploaded by the patient to the web portal and the diabetes management system.

参照以上问题,并且带有发展糖尿病治疗的目的,图1图示了用于存储和传输医学数据、使用数据、便携式医学设备设置并且累积和评估统计量和跨分布式计算环境可用的其他相关信息的示例性糖尿病管理系统(“DMS”)10。作为非限制性示例,这样的医学数据、使用数据和有关信息可能包括血糖测量、碳水化合物消耗、基础率、用药治疗、依循性信息和统计量、用户和设备设置、警报和提醒、医师约会、实验室测试结果、用户录入的笔记、报告和图表以及位置信息。With reference to the above issues, and with the goal of developing diabetes treatments, FIG1 illustrates an exemplary diabetes management system ("DMS") 10 for storing and transmitting medical data, usage data, portable medical device settings, and accumulating and evaluating statistics and other relevant information available across a distributed computing environment. As non-limiting examples, such medical data, usage data, and related information may include blood glucose measurements, carbohydrate consumption, basal rates, medication regimens, compliance information and statistics, user and device settings, alarms and reminders, physician appointments, laboratory test results, user-entered notes, reports and charts, and location information.

糖尿病管理系统10可以一般地包括患者数据系统12、保健专业人员数据系统14、网络16和一个或多个服务器计算机18。如以下将更加详细地解释的,糖尿病管理系统10可以被配置成使得数据和信息经由网络16电子地发送到患者数据系统12、保健专业人员数据系统14和服务器计算机18和从其接收。The diabetes management system 10 may generally include a patient data system 12, a healthcare professional data system 14, a network 16, and one or more server computers 18. As will be explained in greater detail below, the diabetes management system 10 may be configured such that data and information is electronically sent to and received from the patient data system 12, the healthcare professional data system 14, and the server computers 18 via the network 16.

图3中图示的糖尿病管理系统10’还可以一般地包括便携式医学设备28,诸如记录设备或血糖仪,以用于测量和存储某些医学数据或信息,包括血糖测量。The diabetes management system 10' illustrated in FIG3 may also generally include a portable medical device 28, such as a recording device or a blood glucose meter, for measuring and storing certain medical data or information, including blood glucose measurements.

便携式医学设备28可以例如是包括配置成接收具有用于接收来自患者的液体样本的反应区域的医学测试条的端口的手持设备。便携式医学设备28可以包括可与插入在端口中的测试条协作操作并且配置成测量驻留在条中的液体样本中的葡萄糖并且将标识信息与葡萄糖测量相关联的内部血糖仪。便携式医学设备28还可以包括向患者选择性地提供指令、消息和/或治疗推荐的用户接口。便携式医学设备28可以与诸如移动通信设备、膝上型计算机、平板或能够与便携式医学设备28协作并且显示指令、消息、提醒、警报、治疗推荐等的其他设备之类的其他便携式设备配对。The portable medical device 28 can be, for example, a handheld device comprising a port configured to receive a medical test strip having a reaction area for receiving a liquid sample from a patient. The portable medical device 28 can include an internal blood glucose meter that can operate in cooperation with a test strip inserted in the port and is configured to measure the glucose in the liquid sample residing in the strip and associate identification information with the glucose measurement. The portable medical device 28 can also include a user interface that selectively provides instructions, messages, and/or treatment recommendations to the patient. The portable medical device 28 can be paired with other portable devices such as a mobile communication device, a laptop computer, a tablet, or other devices that can cooperate with the portable medical device 28 and display instructions, messages, reminders, alarms, treatment recommendations, etc.

便携式医学设备28可以可操作成通过并入其中的诸如硬连线数据端口或诸如蓝牙接收器之类的无线数据端口之类的数据传输设备向患者计算设备20和保健专业人员计算设备24中的至少一个发送医学数据、使用数据或其他相关信息。便携式医学设备28可以与附着到便携式医学设备传输的任何数据的唯一标识符或安全代码相关联。因此,在这种数据传输方法中,患者或其他用户在经由网络16传输数据之前可以不被要求录入用户名、口令或其他安全代码。The portable medical device 28 may be operable to transmit medical data, usage data, or other relevant information to at least one of the patient computing device 20 and the healthcare professional computing device 24 via a data transmission device incorporated therein, such as a hardwired data port or a wireless data port such as a Bluetooth receiver. The portable medical device 28 may be associated with a unique identifier or security code attached to any data transmitted by the portable medical device. Thus, in this data transmission method, the patient or other user may not be required to enter a username, password, or other security code before transmitting data via the network 16.

应当理解的是,患者可以操作多个便携式设备以便管理其糖尿病治疗。设备可以在功能和/或设计方面相同或不同。预计到每一个设备可以与糖尿病管理系统一起使用,并且多个设备可以手动或自动传输数据。It should be understood that a patient can operate multiple portable devices to manage their diabetes treatment. The devices can be the same or different in function and/or design. It is contemplated that each device can be used with a diabetes management system and that multiple devices can transmit data manually or automatically.

患者数据系统12可以包括通过有线或诸如WiFi之类的无线连接可操作连接到网络16并且与其通信的至少一个患者计算设备20。作为示例,患者计算设备20可以是台式计算机或移动通信设备,诸如电子平板或智能电话。患者计算设备20可以包括数据输入设备、处理器、存储器和输出设备。数据输入设备可以是触摸屏、键盘、鼠标、麦克风、硬连线数据端口,诸如通用串行总线端口,或者诸如蓝牙接收器之类的无线数据端口。处理器可以连接到数据输入设备、存储器和输出设备。在示例实施例中,处理器包括通用处理器。在另一示例实施例中,处理器包括专用集成电路。输出设备包括显示器、扬声器等。The patient data system 12 may include at least one patient computing device 20 operatively connected to and in communication with the network 16 via a wired or wireless connection, such as WiFi. By way of example, the patient computing device 20 may be a desktop computer or a mobile communication device, such as an electronic tablet or smartphone. The patient computing device 20 may include a data input device, a processor, a memory, and an output device. The data input device may be a touch screen, a keyboard, a mouse, a microphone, a hardwired data port, such as a universal serial bus (USB) port, or a wireless data port, such as a Bluetooth receiver. The processor may be connected to the data input device, the memory, and the output device. In an exemplary embodiment, the processor comprises a general-purpose processor. In another exemplary embodiment, the processor comprises an application-specific integrated circuit (ASIC). Output devices may include a display, a speaker, and the like.

参照图1和2,在患者数据系统12的一个实施例中,用户(例如患者)可以经由用于经由网络16的传输的数据输入设备将医学数据、使用数据或诸如血糖测量之类的其他相关信息录入到基于web的系统或患者计算设备20上的账户中。在经由网络16录入或传输数据之前,可以要求用户录入用户名、口令或其他安全代码以便确保数据的精确传输和存储。1 and 2 , in one embodiment of the patient data system 12, a user (e.g., a patient) may enter medical data, usage data, or other relevant information, such as blood glucose measurements, into an account on a web-based system or patient computing device 20 via a data entry device for transmission via a network 16. Prior to entering or transmitting data via the network 16, the user may be required to enter a username, password, or other security code to ensure accurate transmission and storage of the data.

保健专业人员数据系统14可以包括通过有线或诸如WiFi之类的无线连接可操作连接到网络16并且与其通信的至少一个保健专业人员计算设备24。医师或具有访问保健专业人员计算设备24的适当凭证的其他人员可以利用网络16下载和查看存储在服务器计算机18上的医学数据、使用数据或诸如血糖测量之类的其他相关信息。作为示例,保健专业人员计算设备24可以是台式计算机或移动通信设备,诸如电子平板或智能电话。The healthcare professional data system 14 may include at least one healthcare professional computing device 24 operatively connected to and in communication with the network 16 via a wired or wireless connection, such as WiFi. A physician or other person with appropriate credentials to access the healthcare professional computing device 24 may utilize the network 16 to download and view medical data, usage data, or other relevant information, such as blood glucose measurements, stored on the server computer 18. By way of example, the healthcare professional computing device 24 may be a desktop computer or a mobile communication device, such as an electronic tablet or a smartphone.

保健专业人员计算设备24可以包括数据输入设备、处理器、存储器和输出设备。数据输入设备可以是触摸屏、键盘、鼠标、麦克风、诸如通用串行总线端口之类的硬连线数据端口或诸如蓝牙接收器之类的无线数据端口。处理器可以连接到数据输入设备、存储器和输出设备。在示例实施例中,处理器包括通用处理器。在另一示例实施例中,处理器包括专用集成电路。输出设备包括显示器、扬声器等。The healthcare professional computing device 24 may include a data input device, a processor, a memory, and an output device. The data input device may be a touch screen, a keyboard, a mouse, a microphone, a hardwired data port such as a Universal Serial Bus port, or a wireless data port such as a Bluetooth receiver. The processor may be connected to the data input device, the memory, and the output device. In an exemplary embodiment, the processor comprises a general-purpose processor. In another exemplary embodiment, the processor comprises an application-specific integrated circuit. Output devices may include a display, a speaker, and the like.

参照图1和2,一个或多个服务器计算机18可以包括处理器、输入设备、输出设备和包括数据库或数据储存库26的存储器。处理器连接到存储器、输入设备和输出设备。在示例实施例中,处理器包括通用处理器。在另一示例实施例中,处理器包括专用集成电路。输入设备包括键盘、鼠标、触摸板、跟踪板等。输出设备包括显示器、扬声器等。服务器计算机18和数据库26可以通过有线或无线连接可操作连接到网络16并且与其通信。服务器计算机18可以可操作成经由网络16向数据库26发送和接收数据,诸如从患者数据系统12接收的血糖测量,以用于存储和稍后检索。如以下将讨论的,经由网络16发送的数据和信息可以在存储在位于服务器计算机18上或者以其他方式由服务器计算机18可访问的数据库26中之前被分配到唯一web门户或等同的患者账户。1 and 2 , one or more server computers 18 may include a processor, input devices, output devices, and memory including a database or data repository 26. The processor is connected to the memory, input devices, and output devices. In an exemplary embodiment, the processor comprises a general-purpose processor. In another exemplary embodiment, the processor comprises an application-specific integrated circuit. Input devices include a keyboard, a mouse, a touchpad, a trackpad, etc. Output devices include a display, a speaker, etc. The server computer 18 and the database 26 may be operably connected to and in communication with the network 16 via a wired or wireless connection. The server computer 18 may be operable to send and receive data, such as blood glucose measurements received from the patient data system 12, to the database 26 via the network 16 for storage and later retrieval. As will be discussed below, data and information sent via the network 16 may be assigned to a unique web portal or equivalent patient account before being stored in the database 26 located on the server computer 18 or otherwise accessible by the server computer 18.

图3图示了糖尿病管理系统10’的可替换实施例。糖尿病管理系统10’的可替换实施例可以类似于图1中所示的实施例,并且包括患者数据系统12、保健专业人员数据系统14、网络16和至少一个服务器计算机18。患者数据系统12可以包括通过有线或诸如WiFi之类的无线连接可操作连接到网络16并且与其通信的至少一个患者计算设备20。保健专业人员数据系统14可以包括通过有线或诸如WiFi之类的无线连接可操作连接到网络16并且与其通信的至少一个保健专业人员计算设备24,医师或具有对保健专业人员计算设备的适当访问的其他人员可以通过其下载和查看经由网络16从患者计算设备20发送的医学数据、使用数据或其他相关信息,诸如血糖测量。FIG3 illustrates an alternative embodiment of a diabetes management system 10′. The alternative embodiment of the diabetes management system 10′ can be similar to the embodiment shown in FIG1 and include a patient data system 12, a healthcare professional data system 14, a network 16, and at least one server computer 18. The patient data system 12 can include at least one patient computing device 20 operatively connected to and in communication with the network 16 via a wired or wireless connection, such as WiFi. The healthcare professional data system 14 can include at least one healthcare professional computing device 24 operatively connected to and in communication with the network 16 via a wired or wireless connection, such as WiFi, through which a physician or other person with appropriate access to the healthcare professional computing device can download and view medical data, usage data, or other relevant information, such as blood glucose measurements, sent from the patient computing device 20 via the network 16.

便携式医学设备28可以配置成以规律、可编程间隔、在用户选择的变化时间处、在取得血糖测量时实时地或者当血糖测量达到可以由患者或保健专业人员设置和远程调节的某些阈值设备设置水平时向患者计算设备20、保健专业人员计算设备24和一个或多个服务器计算机18中的至少一个传输数据。The portable medical device 28 may be configured to transmit data to at least one of the patient computing device 20, the healthcare professional computing device 24, and the one or more server computers 18 at regular, programmable intervals, at user-selected varying times, in real time as blood glucose measurements are taken, or when blood glucose measurements reach certain threshold device-set levels that may be set and remotely adjusted by the patient or healthcare professional.

参照图4,图示了供糖尿病管理系统10使用的软件架构系统30的一个实施例。软件架构系统30可以可操作成允许通过网络16从便携式医学设备28和在患者数据系统12、一个或多个服务器计算机18和保健专业人员数据系统14之间传输和操纵医学数据、使用数据和诸如血糖测量之类的其他相关信息。4 , one embodiment of a software architecture system 30 is illustrated for use with the diabetes management system 10. The software architecture system 30 may be operable to allow the transfer and manipulation of medical data, usage data, and other relevant information, such as blood glucose measurements, from the portable medical device 28 and between the patient data system 12, one or more server computers 18, and the healthcare professional data system 14 over the network 16.

软件架构系统30可以包括设备转移组件32。设备转移组件32可以存储在一个或多个服务器计算机18上以用于通过网络16传输和安装在患者计算设备20和保健专业人员计算设备24上。设备转移组件32到患者计算设备20或保健专业人员计算设备24上的安装将允许这样的设备向安装在服务器计算机18上的糖尿病管理应用33发送诸如血糖测量之类的数据和信息。当便携式医学设备28向患者计算设备20或保健专业人员计算设备24发送数据时,设备转移组件32可操作成经由网络16向服务器计算机18传递数据而没有将数据存储在设备转移组件32或患者计算设备20中。医学设备应用34可以安装在便携式医学设备28上以促进与设备转移组件32的数据和信息交换,如以上所描述的那样。经由设备转移组件32发送的数据可以包括对数据从其接收的特定患者和/或便携式医学设备28而言唯一的标识符代码。标识符代码可以允许设备转移组件32和数据库26高效地发送、存储和从数据库26内的唯一位置或患者账户检索数据。The software architecture system 30 may include a device transfer component 32. The device transfer component 32 may be stored on one or more server computers 18 for transmission and installation on patient computing devices 20 and healthcare professional computing devices 24 via the network 16. Installation of the device transfer component 32 on a patient computing device 20 or healthcare professional computing device 24 allows such device to send data and information, such as blood glucose measurements, to a diabetes management application 33 installed on the server computer 18. When a portable medical device 28 sends data to the patient computing device 20 or healthcare professional computing device 24, the device transfer component 32 may be operable to pass the data to the server computer 18 via the network 16 without storing the data on the device transfer component 32 or the patient computing device 20. A medical device application 34 may be installed on the portable medical device 28 to facilitate data and information exchange with the device transfer component 32, as described above. Data sent via the device transfer component 32 may include an identifier code unique to the specific patient and/or portable medical device 28 from which the data was received. The identifier code may allow device transfer component 32 and database 26 to efficiently send, store, and retrieve data from a unique location within database 26 or a patient account.

在通过网络16转移数据和信息之前,可以要求用户将便携式医学设备28与一个或多个服务器18上创建的或其可访问的唯一患者账户链接或相关联。验证可以通过首先允许便携式医学设备28经由诸如USB端口或蓝牙接收器之类的输入设备与患者计算设备20通信来完成。便携式医学设备28可以被分配唯一的标识代码或验证令牌。在下载和运行设备转移组件32并且允许便携式医学设备28与个人计算设备20通信之后,便携式医学设备的验证令牌可以被分配到适当的患者账户。一旦便携式医学设备28的验证令牌已经被分配到患者账户,医学数据、使用数据和其他相关信息可以通过设备转移组件32转移和分配到数据库26中的适当患者账户。Before transferring data and information over the network 16, the user may be required to link or associate the portable medical device 28 with a unique patient account created on or accessible to one or more servers 18. Authentication can be accomplished by first allowing the portable medical device 28 to communicate with the patient computing device 20 via an input device such as a USB port or a Bluetooth receiver. The portable medical device 28 may be assigned a unique identification code or authentication token. After downloading and running the device transfer component 32 and allowing the portable medical device 28 to communicate with the personal computing device 20, the authentication token for the portable medical device may be assigned to the appropriate patient account. Once the authentication token for the portable medical device 28 has been assigned to the patient account, medical data, usage data, and other relevant information may be transferred and assigned to the appropriate patient account in the database 26 via the device transfer component 32.

在数据转移过程的可替换实施例中,设备转移组件32可以被分配唯一的标识代码。在通过网络16从便携式医学设备28转移数据和信息之前,可以要求用户将设备转移组件32的唯一标识代码与患者的账户相关联。来自便携式医学设备28的数据和信息可以在通过网络的传输之前链接到设备转移组件32的唯一标识代码,并且因此分配到数据库26中的适当患者账户。In an alternative embodiment of the data transfer process, the device transfer component 32 may be assigned a unique identification code. Prior to transferring data and information from the portable medical device 28 via the network 16, the user may be required to associate the unique identification code of the device transfer component 32 with the patient's account. The data and information from the portable medical device 28 may be linked to the unique identification code of the device transfer component 32 prior to transmission via the network and, therefore, assigned to the appropriate patient account in the database 26.

在已经从设备转移组件32向位于服务器18上的患者账户转移数据之后,软件架构系统30可以允许这样的数据进一步从患者账户经由设备转移组件32转移到经授权的健康专业人员计算设备24和患者计算设备20。数据从位于服务器18上的数据库26中的患者账户的转移可以要求将患者账户与安装在健康专业人员计算设备24上的设备转移组件32链接。After data has been transferred from the device transfer component 32 to a patient account located on the server 18, the software architecture system 30 may allow such data to be further transferred from the patient account to an authorized health professional computing device 24 and a patient computing device 20 via the device transfer component 32. The transfer of data from the patient account in the database 26 located on the server 18 may require linking the patient account with the device transfer component 32 installed on the health professional computing device 24.

软件架构系统30还可以允许患者、保健专业人员或其他用户创建涉及包含在其中的数据和信息的定制报告或执行关于包含在软件架构系统内或外部的信息的研究。此外,软件架构系统30可以可操作成提供关于可能从患者数据系统12或保健专业人员数据系统14丢失的数据和信息的数据备份和恢复服务。The software architecture system 30 may also allow patients, healthcare professionals, or other users to create customized reports relating to the data and information contained therein or to perform research on information contained within or external to the software architecture system. In addition, the software architecture system 30 may be operable to provide data backup and recovery services regarding data and information that may be lost from the patient data system 12 or the healthcare professional data system 14.

参照图5,图示了供糖尿病管理系统10使用的软件架构系统30的另一实施例。服务器计算机18上的数据库26可以与配置成累积涉及指定时间段内的医学数据和使用数据的统计量的累积器设备或模块36通信。数据库26还可以与配置成收集、评估和生成涉及供糖尿病管理系统33使用的医学数据和使用数据的统计量的统计量评估器设备或模块38通信。统计量评估器38可以与包含涉及被收集和分析的医学数据和使用数据的基准信息和标准以及涉及可以编程在其中的各种治疗准则的信息的推荐规则集合40通信。治疗准则可以包括最小和最大接受值,以及用于正常和超范围数据和/或统计量的边界。在各种方面中,推荐规则集合40可以由管理员或保健提供者更新或修改。累积器设备36和统计量评估器38可以通过糖尿病管理系统应用33来评价。Referring to FIG5 , another embodiment of a software architecture system 30 for use with the diabetes management system 10 is illustrated. A database 26 on the server computer 18 can communicate with an accumulator device or module 36 configured to accumulate statistics related to medical data and usage data over a specified time period. The database 26 can also communicate with a statistics evaluator device or module 38 configured to collect, evaluate, and generate statistics related to the medical data and usage data for use by the diabetes management system 33. The statistics evaluator 38 can communicate with a recommendation rule set 40 containing baseline information and standards related to the collected and analyzed medical data and usage data, as well as information related to various treatment guidelines that can be programmed therein. Treatment guidelines can include minimum and maximum acceptance values, as well as boundaries for normal and out-of-range data and/or statistics. In various aspects, the recommendation rule set 40 can be updated or modified by an administrator or healthcare provider. The accumulator device 36 and statistics evaluator 38 can be evaluated by the diabetes management system application 33.

参照图2,在软件架构系统30’的另一实施例中,用户可以经由患者计算设备20上的web浏览器从一个或多个服务器计算机18和数据库26发送和接收数据,替代于在患者计算设备上下载和利用设备转移组件32。在软件架构系统30’中,服务器计算机18可以包括设备转移组件32,其允许用户向服务器计算机18发送数据和信息以用于存储在数据库26中,以及用于经由网络16进一步传输到保健专业人员计算设备24。用户可以通过将指定用于糖尿病管理系统的URL直接录入到web浏览器中来访问糖尿病管理系统10和软件架构系统30’。2 , in another embodiment of a software architecture system 30′, a user may send and receive data from one or more server computers 18 and databases 26 via a web browser on a patient computing device 20, instead of downloading and utilizing a device transfer component 32 on the patient computing device. In the software architecture system 30′, the server computer 18 may include a device transfer component 32 that allows a user to send data and information to the server computer 18 for storage in the database 26 and for further transmission to the healthcare professional computing device 24 via the network 16. The user may access the diabetes management system 10 and the software architecture system 30′ by entering a URL designated for the diabetes management system directly into a web browser.

在通过网络16向服务器计算机18转移数据之前,可以要求用户创建唯一的患者账户和安全凭证,诸如用户名和口令,以确保数据库26中的唯一且安全的存储位置。还可以要求用户将便携式医学设备28验证令牌与患者账户相关联或链接。一旦用户已经创建了患者账户并且将便携式医学设备28验证代码链接到患者账户,可以准许用户向服务器计算机18和从服务器计算机18转移数据和信息而没有以其他方式登录到患者账户。在糖尿病管理系统10的一个方面中,经由web浏览器对服务器18的访问可以允许用户向数据库26中的患者账户传输诸如血糖测量、患者重量、就餐信息和类似信息之类的数据。在糖尿病管理系统10的另一方面中,经由web浏览器对服务器18的访问可以允许用户至少部分地基于从用户传输的数据创建和查看报告、图表和其他信息。Before transferring data to the server computer 18 via the network 16, the user may be required to create a unique patient account and security credentials, such as a username and password, to ensure a unique and secure storage location in the database 26. The user may also be required to associate or link a portable medical device 28 verification token with the patient account. Once the user has created a patient account and linked the portable medical device 28 verification code to the patient account, the user may be permitted to transfer data and information to and from the server computer 18 without otherwise logging into the patient account. In one aspect of the diabetes management system 10, access to the server 18 via a web browser may allow the user to transfer data, such as blood glucose measurements, patient weight, meal information, and the like, to the patient account in the database 26. In another aspect of the diabetes management system 10, access to the server 18 via a web browser may allow the user to create and view reports, charts, and other information based, at least in part, on data transferred from the user.

患者数据系统12、保健专业人员数据系统14和服务器计算机18之间的通信可以利用与安全套接字层(SSL)安全协议组合的HTTP基本验证。还设想到本领域中已知的其他通信和安全协议。Communications between the patient data system 12, the healthcare professional data system 14, and the server computer 18 may utilize HTTP Basic Authentication combined with the Secure Sockets Layer (SSL) security protocol. Other communication and security protocols known in the art are also contemplated.

在各种方面中,本技术使用与糖尿病管理系统或管理应用通信的web门户以执行涉及保健提供者账户、患者账户或二者的各种功能。web浏览器或基于web的应用可以用于执行类似的功能。例如,保健提供者可以设置有第一或主web门户账户以帮助管理多个不同患者的治疗,每一个患者具有从与糖尿病管理系统相关联的服务器计算机可访问的相应患者账户。保健提供者可以能够将其账户配置成显示来自具有通过保健专业人员的账户可访问的web门户患者账户的各种患者的某些数据、统计量和/或使用数据。数据的考查可以允许保健提供者更好地评价患者的健康,并且基于最新的和历史数据调节治疗疗程。In various aspects, the present technology uses a web portal that communicates with a diabetes management system or management application to perform various functions involving healthcare provider accounts, patient accounts, or both. A web browser or web-based application can be used to perform similar functions. For example, a healthcare provider can be provided with a first or primary web portal account to help manage the treatment of multiple different patients, each patient having a corresponding patient account accessible from a server computer associated with the diabetes management system. The healthcare provider may be able to configure its account to display certain data, statistics, and/or usage data from various patients having web portal patient accounts accessible through the healthcare professional's account. Review of the data can allow the healthcare provider to better assess the patient's health and adjust the course of treatment based on the latest and historical data.

图7-13图示了可以与糖尿病管理系统、管理应用、web浏览器、web门户账户和有关软件架构一起使用的示例性图形用户接口(GUI)。7-13 illustrate exemplary graphical user interfaces (GUIs) that may be used with the diabetes management system, management application, web browser, web portal account, and related software architecture.

在糖尿病管理系统的使用期间的各种点处,可以验证对信息的访问和请求或改变的处理。验证可以使用各种技术完成,包括但不限于用户名和/或口令凭证、许可、唯一标识符、安全问题或其他标识的验证。验证还可以包括对一个或多个用户的征求或确认,其寻求所提出的请求的确认或承认。图7和8图示了GUI欢迎屏幕。在一个示例中,欢迎屏幕可以开始验证过程,并且随后提供对账户信息、历史、统计量和包括手动录入、上传或以其他方式从患者所使用的手持或便携式医学设备获取的血糖、胰岛素和碳水化合物值的数据和所选特征的概览的访问。At various points during the use of the diabetes management system, access to information and the processing of requests or changes can be verified. Verification can be accomplished using various techniques, including but not limited to verification of username and/or password credentials, permissions, unique identifiers, security questions or other identifications. Verification can also include solicitation or confirmation of one or more users, which seeks confirmation or acknowledgment of the request made. Figures 7 and 8 illustrate a GUI welcome screen. In one example, the welcome screen can begin the verification process and subsequently provide access to account information, history, statistics, and data including blood glucose, insulin, and carbohydrate values manually entered, uploaded, or otherwise obtained from the handheld or portable medical device used by the patient, and an overview of selected features.

除了一般被视为对于糖尿病治疗和管理控制有用的典型的逻辑和测试信息之外,web门户可以被配置成收集和使用保健提供者和/或患者的地理位置以便遵照对于诸如不同州或国家之类的不同地理位置可能存在的某些规章和/或遵从疗程。诸如对医学患者数据和个人数据的引用之类的数据的各种部分可以被加密以得到患者安全性和机密性。In addition to typical logic and test information generally considered useful for diabetes treatment and management control, the web portal can be configured to collect and use the geographic location of the healthcare provider and/or patient in order to comply with certain regulations and/or compliance regimens that may exist for different geographic locations, such as different states or countries. Various portions of the data, such as references to medical patient data and personal data, can be encrypted for patient security and confidentiality.

图6是图示了共享信息和管理具有医学条件的患者的诊断的方法的一个实施例的流程图。参照方法步骤100,可以在一个或多个服务器上创建web门户账户。账户可以通过适当的管理员或保健提供者来创建。web门户账户然后可以与特定患者和/或便携式医学设备相关联,如步骤110中所示。如以上所讨论的,向患者和保健提供者提供适当的访问权限和授权,如步骤120中所示。在各种方面中,具有适当凭证的患者和/或保健提供者(经授权的用户)可以访问存储在糖尿病管理系统内的各种数据。例如,经授权的用户可以考查历史数据并且基于存储在其中的数据确定治疗推荐。FIG6 is a flow chart illustrating an embodiment of a method for sharing information and managing diagnoses for patients with medical conditions. Referring to method step 100, a web portal account can be created on one or more servers. The account can be created by an appropriate administrator or healthcare provider. The web portal account can then be associated with a specific patient and/or portable medical device, as shown in step 110. As discussed above, appropriate access rights and authorizations are provided to the patient and healthcare provider, as shown in step 120. In various aspects, patients and/or healthcare providers (authorized users) with appropriate credentials can access various data stored in the diabetes management system. For example, an authorized user can review historical data and determine treatment recommendations based on the data stored therein.

参照步骤130,从便携式医学设备接收医学数据和使用数据。在各种方面中,患者可以登录到糖尿病管理系统中以便手动录入或记录诸如血糖测量、胰岛素值、就餐信息、依循性证据等之类的医学数据。信息还可以由患者或保健提供者自动转移到系统中。如以上所讨论的,诸如患者或保健提供者之类的用户可以将一个或多个便携式医学设备连接到糖尿病管理系统并且在系统内导航至设备。用户然后可以选择适当的设备(如果连接多于一个设备的话)并且指令系统向糖尿病管理系统转移医学数据、使用数据和/或用户设置。数据可以以批量方式或者在取得各个测量之后转移到web门户账户。Referring to step 130, medical data and usage data are received from the portable medical device. In various aspects, a patient can log into the diabetes management system to manually enter or record medical data such as blood glucose measurements, insulin values, meal information, compliance evidence, etc. The information can also be automatically transferred to the system by the patient or healthcare provider. As discussed above, a user such as a patient or healthcare provider can connect one or more portable medical devices to the diabetes management system and navigate to the device within the system. The user can then select the appropriate device (if more than one device is connected) and instruct the system to transfer medical data, usage data, and/or user settings to the diabetes management system. The data can be transferred to a web portal account in batches or after each measurement is taken.

参照步骤140和150,可以在一段时间内累积统计量,其中累积器设备36和统计量评估器38关于治疗准则分析医学数据和使用数据,如以上所讨论的那样。统计量可以与适当的web门户账户相关联,以供患者和保健提供者访问,如步骤160中所示。With reference to steps 140 and 150, statistics may be accumulated over a period of time, wherein the accumulator device 36 and the statistics evaluator 38 analyze the medical data and the usage data with respect to the treatment guidelines, as discussed above. The statistics may be associated with an appropriate web portal account for access by the patient and the healthcare provider, as shown in step 160.

在各种方面中,参照步骤170,当至少一个统计量满足或超过治疗准则时,可以向患者或保健提供者发送治疗推荐。治疗推荐可以包括指令患者调节一个或多个门户医学设备上的用户或设备设置。设备设置可以包括例如,设备何时进行测量、设备何时递送胰岛素(如果适用的话)、设备何时提醒患者进食、标准胰岛素:碳水化合物比、基础率、最大用药量、校准设置、实用程序设置和报警设置。In various aspects, referring to step 170, when at least one statistic meets or exceeds a treatment criterion, a treatment recommendation can be sent to the patient or healthcare provider. The treatment recommendation can include instructing the patient to adjust user or device settings on one or more portal medical devices. Device settings can include, for example, when the device takes a measurement, when the device delivers insulin (if applicable), when the device reminds the patient to eat, standard insulin:carbohydrate ratio, basal rate, maximum dosage, calibration settings, utility settings, and alarm settings.

各种设备设置可以上传到糖尿病管理系统。在某些方面中,便携式医学设备的至少一个设备设置可以例如从一个或多个服务器利用可选地由保健提供者基于期望的治疗推荐而授权、批准或发起的调节来远程调节。作为示例,保健提供者可以使用web门户调节一个或多个设置,并且下一次便携式医学设备连接到糖尿病管理系统,设备设置将与便携式医学设备同步。在某些方面中,糖尿病管理应用中的逻辑可以编程为在向患者发送治疗推荐之前征求来自保健提供者的输入。Various device settings can be uploaded to the diabetes management system. In certain aspects, at least one device setting of the portable medical device can be remotely adjusted, for example, from one or more servers, with adjustments optionally authorized, approved, or initiated by a healthcare provider based on a desired treatment recommendation. As an example, the healthcare provider can adjust one or more settings using a web portal, and the next time the portable medical device is connected to the diabetes management system, the device settings will be synchronized with the portable medical device. In certain aspects, logic in the diabetes management application can be programmed to solicit input from the healthcare provider before sending a treatment recommendation to the patient.

例如,可以使一个或多个所提出的治疗推荐和/或所建议的设备设置改变对保健提供者可用,并且保健提供者选择至少一个所提出的治疗推荐以用于发送给患者,或者对便携式医学设备做出的设备设置改变。一旦设备设置改变被接受并且对设备做出,设备可以向糖尿病管理系统提供确认消息。确认消息还可以例如经由消息、电子邮件或通过web门户做出的警报提供给保健提供者,或者通过便携式设备的使用直接提供给保健提供者。For example, one or more proposed treatment recommendations and/or suggested device setting changes can be made available to a healthcare provider, and the healthcare provider selects at least one proposed treatment recommendation for transmission to the patient, or a device setting change to be made to the portable medical device. Once the device setting change is accepted and made to the device, the device can provide a confirmation message to the diabetes management system. The confirmation message can also be provided to the healthcare provider, for example, via a message, email, or alert made through a web portal, or directly to the healthcare provider through the use of the portable device.

在另一示例中,患者可以将多个设备设置上传到糖尿病管理系统。上传过程可以是手动或自动的,这取决于便携式医学设备。患者可以向保健提供者授予查看和调节存储在糖尿病管理系统内的设备设置的访问权限。保健提供者可以经由web浏览器和联网的web门户账户连接到糖尿病管理系统。在可以包括除设备设置或使用数据之外的其他相关数据(诸如食物摄入、锻炼惯例等)的考查的患者数据的考查之后,治疗推荐可以使用web门户账户通过糖尿病管理系统提交以供显示,并且还可以作为电子消息、警报或提醒而直接提供给便携式医学设备。In another example, a patient can upload multiple device settings to a diabetes management system. The upload process can be manual or automatic, depending on the portable medical device. The patient can grant access rights to a healthcare provider to view and adjust the device settings stored in the diabetes management system. The healthcare provider can connect to the diabetes management system via a web browser and a networked web portal account. After reviewing the patient data, which can include review of other relevant data in addition to device settings or usage data (such as food intake, exercise routine, etc.), treatment recommendations can be submitted for display through the diabetes management system using the web portal account and can also be provided directly to the portable medical device as an electronic message, alarm, or reminder.

图9图示了用于诸如Accu-Check 360°之类的特定便携式医学设备的设备设置。如所示,设备设置可以包括优选测量单位和警告参数,诸如过高和过低血糖测量限制。设备设置可以包括涉及用药建议的特征,包括上限和下限血糖单位、胰岛素:碳水化合物比和胰岛素敏感性因素。可以提供针对锻炼惯例的各种健康事件设置。选项可以对用户可用以启用或禁用某些特征。设置的组可以保存为模板,并且之前的设置可以保存在档案中以用于稍后的考查、统计量分析和历史目的。FIG9 illustrates the device settings for a particular portable medical device such as the Accu-Check 360°. As shown, the device settings may include preferred measurement units and warning parameters, such as high and low blood glucose measurement limits. The device settings may include features related to medication recommendations, including upper and lower blood glucose units, insulin:carbohydrate ratios, and insulin sensitivity factors. Various health event settings may be provided for exercise routines. Options may be available to the user to enable or disable certain features. Groups of settings may be saved as templates, and previous settings may be saved in archives for later review, statistical analysis, and historical purposes.

图10图示了用于患者所使用的多个设备的汇总接口。在这方面,患者可以具有用于家庭使用的第一便携式医学设备和用于办公室使用的第二便携式医学设备。如所示,移动通信设备也可以被配置用于该所选患者账户。每一个设备可以具有其自身的设置和报告,并且接口可以提供包括针对每一个设备的最后上传日期和时间的各种数据的列表。在各种方面,所显示的信息可以被过滤、通过模板选择和以其他方式由用户可定制。软件更新和安装器也可以通过接口可用。FIG10 illustrates a summary interface for multiple devices used by a patient. In this regard, a patient may have a first portable medical device for home use and a second portable medical device for office use. As shown, a mobile communication device may also be configured for the selected patient account. Each device may have its own settings and reports, and the interface may provide a list of various data including the last upload date and time for each device. In various aspects, the displayed information may be filtered, selected through templates, and otherwise customizable by the user. Software updates and installers may also be available through the interface.

图11图示了针对特定设备的设备设置报告的一个示例。报告可以包括医师约会的提醒、实验室测试、泵提醒设置、测试提醒事件、注射提醒和其他报警特征。An example of a device settings report for a particular device is illustrated in Figure 11. The report may include reminders for physician appointments, lab tests, pump reminder settings, test reminder events, injection reminders, and other alarm features.

参照图12-13,糖尿病管理系统可以收集指示存储在一个或多个便携式医学设备中的其他地方的医学数据或使用数据与存储在数据库或数据储存库中的数据同步的次数的统计数据。例如,一个或多个服务器计算机可以在每次医学数据或使用数据被上传或以其他方式录入在数据储存库中时递增第一计数器。第一计数器的值可以响应于查看存储在其他地方的数据与存储在数据储存库中的数据同步的次数的用户请求而显示。计数器可以例如通过日期、设备、数据类型等来过滤。12-13 , the diabetes management system can collect statistics indicating the number of times medical data or usage data stored elsewhere in one or more portable medical devices has been synchronized with data stored in a database or data repository. For example, one or more server computers can increment a first counter each time medical data or usage data is uploaded or otherwise entered into the data repository. The value of the first counter can be displayed in response to a user request to view the number of times data stored elsewhere has been synchronized with data stored in the data repository. The counter can be filtered, for example, by date, device, data type, etc.

在其他方面,服务器计算机可以此外或可替换地收集指示便携式医学设备与糖尿病管理系统同步的次数的统计数据。例如,服务器计算机可以在每次便携式医学设备被同步时递增第二计数器。第二计数器的值可以响应于查看便携式医学设备被同步的次数的患者或保健提供者请求而被过滤和显示。In other aspects, the server computer can additionally or alternatively collect statistics indicating the number of times the portable medical device has been synchronized with the diabetes management system. For example, the server computer can increment a second counter each time the portable medical device is synchronized. The value of the second counter can be filtered and displayed in response to a patient or healthcare provider request to view the number of times the portable medical device has been synchronized.

服务器计算机可以此外或可替换地收集指示登录到其web门户账户和/或考查经由web门户账户提供给患者的消息或治疗推荐的患者数目的统计数据。例如,服务器计算机可以在每次患者登陆到web门户账户中时递增第三计数器。第三计时器的值可以响应于查看患者登陆到其web门户账户的次数的用户请求而被过滤和显示。The server computer may additionally or alternatively collect statistics indicating the number of patients who have logged into their web portal accounts and/or reviewed messages or treatment recommendations provided to patients via their web portal accounts. For example, the server computer may increment a third counter each time a patient logs into their web portal account. The value of the third counter may be filtered and displayed in response to a user request to view the number of times a patient has logged into their web portal account.

服务器计算机可以此外或可替换地收集指示患者与保健提供者的交互次数的统计数据。例如,服务器计算机可以在每次患者拜访或与保健提供者进行其他交互时使第四计数器递增。The server computer may additionally or alternatively collect statistics indicating the number of interactions the patient has with the healthcare provider.For example, the server computer may increment a fourth counter each time the patient visits or otherwise interacts with the healthcare provider.

在各种实现中,可以例如与提醒和大量依循性统计量一起使用附加的计数器,如以下更加详细地讨论的那样。服务器计算机可以在预确定的周期中重置以上引用的计数器,诸如一天一次、一周一次等。预确定的周期可以如根据需要修改的那样进行更新。In various implementations, additional counters may be used, for example, with reminders and a number of compliance statistics, as discussed in more detail below. The server computer may reset the above-referenced counters at predetermined intervals, such as once a day, once a week, etc. The predetermined intervals may be updated as needed.

通过利用糖尿病数据管理系统,保健提供者和患者可以容易地存储并且稍后访问涉及患者的医学信息以例如分析关于患者的生理条件、便携式医学设备的操作、治疗、治疗结果、个人习惯等的历史信息。基于这样的历史数据,保健提供者和/或患者可以能够识别趋势、有益实践、不利实践等,并且从而调节或设计利用有益趋势和实践并且避免不利趋势和实践的治疗计划。在某些方面中,数据管理系统包括某些预编程的逻辑,其评估某些统计量和/或患者设备设置并且当统计量或信息在预确定的变化或治疗准则之外时警示患者或保健提供者。By utilizing a diabetes data management system, healthcare providers and patients can easily store and later access medical information related to the patient to, for example, analyze historical information regarding the patient's physiological condition, operation of portable medical devices, treatments, treatment results, personal habits, etc. Based on such historical data, healthcare providers and/or patients can be able to identify trends, beneficial practices, adverse practices, etc., and thereby adjust or design a treatment plan that utilizes beneficial trends and practices and avoids adverse trends and practices. In certain aspects, the data management system includes certain pre-programmed logic that evaluates certain statistics and/or patient device settings and alerts the patient or healthcare provider when the statistics or information are outside of predetermined changes or treatment guidelines.

基于从一个或多个便携式医学设备接收的使用统计量,糖尿病管理系统可以收集和分析涉及相对于所派给的胰岛素的量的胰岛素的推荐量和/或相对于所进行的血糖测量的实际数目的每个预确定的周期(例如每天、每周)所进行的推荐的血糖测量的数目的信息。Based on usage statistics received from one or more portable medical devices, the diabetes management system can collect and analyze information related to the recommended amount of insulin relative to the amount of insulin administered and/or the recommended number of blood glucose measurements taken per predetermined period (e.g., daily, weekly) relative to the actual number of blood glucose measurements taken.

糖尿病管理系统可以包括用于生成或以其他方式提供包含从患者、患者组或相同保健提供者账户内的多个患者组接收的信息的报告的软件。以此方式,患者或患者的保健提供者可以容易地访问关于患者的条件、历史条件、患者便携式医学设备操作或条件等的信息或关于一个或多个所定义的患者组的类似信息的格式化报告。报告可以以糖尿病管理系统提供的各种预定义的格式格式化。可替换地或此外,系统可以允许患者和/或保健提供者设计其自身的报告格式,包括确定在报告中包括什么类型的信息和如何过滤、呈现、显示该信息等。本公开的各种方面针对能够收集和管理针对多个患者的患者信息的综合性系统,多个患者具有多个不同类型的医学设备。The diabetes management system may include software for generating or otherwise providing reports containing information received from a patient, a group of patients, or multiple groups of patients within the same healthcare provider account. In this way, a patient or a patient's healthcare provider can easily access formatted reports of information about the patient's condition, historical conditions, operation or condition of the patient's portable medical device, or similar information about one or more defined patient groups. The reports can be formatted in various predefined formats provided by the diabetes management system. Alternatively or in addition, the system can allow the patient and/or healthcare provider to design their own report formats, including determining what type of information to include in the report and how to filter, present, display, etc. Various aspects of the present disclosure are directed to a comprehensive system capable of collecting and managing patient information for multiple patients, multiple patients having multiple different types of medical devices.

应当理解的是,账户和数据的共享以及合适数据储存库的维护可以通过各种行政指南来管理。这样的行政指南可能需要遵循用于打开、关闭和去激活与数据共享和存储相关联的患者和保健提供者账户二者的某些过程。It should be understood that the sharing of accounts and data and the maintenance of appropriate data repositories can be managed by various administrative guidelines. Such administrative guidelines may require following certain procedures for opening, closing, and deactivating both patient and healthcare provider accounts associated with data sharing and storage.

糖尿病管理系统的所有者或保健提供者自身通过其执行涉及保健提供者账户、患者账户或二者的各种功能的web门户或基于web的浏览器/应用可以提供有某些预确定的过程和/或参数以供使用。The owner of the diabetes management system or the healthcare provider themselves may be provided with certain predetermined procedures and/or parameters for use through a web portal or web-based browser/application through which they perform various functions involving the healthcare provider account, the patient account, or both.

本文所描述的技术可以通过由一个或多个处理器施行的一个或多个计算机程序实现。计算机程序包括存储在非暂时性有形计算机可读介质上的处理器可执行指令。计算机程序还可以包括所存储的数据。非暂时性有形计算机可读介质的非限制性示例是非易失性存储器、磁存储装置和光学存储装置。The techniques described herein can be implemented by one or more computer programs executed by one or more processors. The computer programs include processor-executable instructions stored on a non-transitory, tangible, computer-readable medium. The computer programs may also include stored data. Non-limiting examples of non-transitory, tangible, computer-readable media are nonvolatile memory, magnetic storage devices, and optical storage devices.

以上描述的一些部分在对信息的操作的算法和符号表示方面呈现本文所描述的技术。这些算法描述和表示是数据处理领域技术人员用于最有效地向本领域其他技术人员传达其工作实质的手段。当在功能或逻辑上进行描述时,这些操作要理解成通过计算机程序实现。另外,还已经证明,将操作的这些布置称为模块或者通过功能名称命名有时是方便的而不丧失一般性。Some portions of the above description present the techniques described herein in terms of algorithms and symbolic representations of operations on information. These algorithmic descriptions and representations are a means for those skilled in the art of data processing to most effectively convey the essence of their work to others skilled in the art. When described functionally or logically, these operations are understood to be implemented by computer programs. Additionally, it has been demonstrated that it is sometimes convenient to refer to these arrangements of operations as modules or by functional names without loss of generality.

除非具体陈述,否则如从以上讨论显而易见的,要领会到的是,遍及描述,利用诸如“处理”或“运算”或“计算”或“确定”或“显示”等之类的术语的讨论是指计算机系统或类似的电子计算设备的操纵和变换计算机系统存储器或寄存器或其他这样的信息存储装置、传输或显示设备内的表示为物理(电子)量的动作和过程。Unless specifically stated otherwise, as is apparent from the above discussion, it will be appreciated that throughout the description, discussions utilizing terms such as "processing" or "computing" or "calculating" or "determining" or "displaying" etc. refer to actions and processes within a computer system or similar electronic computing device that manipulate and transform information represented as physical (electronic) quantities within the computer system memory or registers or other such information storage, transmission or display devices.

所描述的技术的某些方面包括以算法形式的本文所描述的过程步骤和指令。应当指出的是,所描述的过程步骤和指令可以体现在软件、固件或硬件中,并且当体现在软件中时可以下载以驻留在实时网络操作系统上并且从实时网络操作系统使用的不同平台操作。Certain aspects of the described techniques include the process steps and instructions described herein in the form of algorithms. It should be noted that the process steps and instructions described can be embodied in software, firmware, or hardware, and when embodied in software can be downloaded to reside on a real-time network operating system and operated from different platforms used by the real-time network operating system.

本公开还涉及用于执行本文中的操作的装置。该装置可以针对所要求的目的特殊地构造,或者其可以包括通过存储在计算机可以访问的计算机可读介质上的计算机程序选择性地激活或者重配置的通用计算机。这样的计算机程序可以存储在有形计算机可读存储介质中,诸如但不限于,任何类型的盘,包括软盘、光学盘、CD-ROM、磁光盘、只读存储器(ROM)、随机存取存储器(RAM)、EPROM、EEPROM、磁或光学卡、专用集成电路(ASIC)或适合用于存储电子指令并且每一个耦合到计算机系统总线的任何类型的介质。另外,在说明书中提到的计算机可以包括单个处理器或者可以是采用用于增加的计算能力的多处理器设计的架构。The present disclosure also relates to an apparatus for performing the operations described herein. The apparatus may be specially constructed for the desired purpose, or it may comprise a general-purpose computer selectively activated or reconfigured by a computer program stored on a computer-readable medium accessible by the computer. Such a computer program may be stored on a tangible computer-readable storage medium, such as, but not limited to, any type of disk, including a floppy disk, an optical disk, a CD-ROM, a magneto-optical disk, a read-only memory (ROM), a random access memory (RAM), an EPROM, an EEPROM, a magnetic or optical card, an application-specific integrated circuit (ASIC), or any other type of medium suitable for storing electronic instructions and each coupled to a computer system bus. In addition, the computers referred to in the specification may include a single processor or may be an architecture employing a multi-processor design for increased computing power.

图14示出糖尿病管理系统的实施例。服务器计算机18可以此外或可替换地收集指示用户点击(输入)数目的统计数据。用户点击的数目可以例如基于通过服务器计算机18的服务统计数据的网站的用户点击数目或同步的糖尿病管理设备的用户输入的总数目来收集。仅仅作为示例,服务器计算机18可以在每次用户点击服务器计算机18服务的网站的超链接时递增第五计数器。第五计数器的值可以响应于查看用户点击网站的数目的用户请求而显示。在各种实现中,服务器计算机18可以在每个预确定的周期内重置第五计数器,诸如一天一次。FIG14 illustrates an embodiment of a diabetes management system. Server computer 18 may additionally or alternatively collect statistics indicating the number of user clicks (entries). The number of user clicks may be collected, for example, based on the number of user clicks on a website served by server computer 18 or the total number of user entries for synchronized diabetes management devices. By way of example only, server computer 18 may increment a fifth counter each time a user clicks a hyperlink on a website served by server computer 18. The value of the fifth counter may be displayed in response to a user request to view the number of user clicks on the website. In various implementations, server computer 18 may reset the fifth counter every predetermined period, such as once a day.

服务器计算机18可以此外或可替换地收集指示各种计算设备操作系统多少次访问服务器计算机18服务的网页的统计数据。示例操作系统包括例如Microsoft WindowsXP, Microsoft Windows Vista, Microsoft Windows 7, Microsoft Windows 8,Microsoft Windows的其他版本, Apple Mountain Lion, Apple iOS, Google Chrome,Google Android, Linux和其他类型的操作系统。服务器计算机18可以对每一个不同类型的操作系统访问网页的次数计数。在各种实现中,服务器计算机18可以收集网页被两个或更多不同的操作系统访问的累计次数。针对一个或多个操作系统收集的数目可以响应于查看门户类型访问数目的用户请求而显示。在各种实现中,服务器计算机18可以在每一个预确定的周期内重置数目,诸如一天一次。Server computer 18 may also or alternatively collect statistics indicating how many times various computing device operating systems have accessed the webpage served by server computer 18. Example operating systems include, for example, Microsoft Windows XP, Microsoft Windows Vista, Microsoft Windows 7, Microsoft Windows 8, other versions of Microsoft Windows, Apple Mountain Lion, Apple iOS, Google Chrome, Google Android, Linux, and other types of operating systems. Server computer 18 may count the number of times each different type of operating system has accessed the webpage. In various implementations, server computer 18 may collect the cumulative number of times the webpage has been accessed by two or more different operating systems. The collected counts for one or more operating systems may be displayed in response to a user request to view portal-type access counts. In various implementations, server computer 18 may reset the counts every predetermined period, such as once a day.

示例Example

通过以下非限制性示例来进一步说明本技术。The present technology is further illustrated by the following non-limiting examples.

示例1Example 1

当考查针对web门户中的特定患者收集的医学数据和使用数据时,保健提供者注意到针对一个患者的统计量指示他自从大约一周之前开始的新疗法调节已经具有五个过高血糖测量。在某些方面中,糖尿病管理应用将已经收集和分析了该数据或者对应于该数据的统计量,并且可以向保健提供者提供已经存在过高或过低血糖读数的多个实例的警报。可替换地,糖尿病管理应用可以检测到存在使用数据中的不符,例如用户在给定时间段内尚未遵从用药建议器设置或者尚未进行适当量的血糖测量。While reviewing the medical and usage data collected for a particular patient in a web portal, a healthcare provider may notice that statistics for one patient indicate that the patient has had five excessively high blood sugar readings since starting a new therapy regimen approximately a week ago. In some aspects, the diabetes management application will have already collected and analyzed this data, or statistics corresponding to this data, and may provide an alert to the healthcare provider that there have been multiple instances of excessively high or low blood sugar readings. Alternatively, the diabetes management application may detect that there are discrepancies in the usage data, such as that the user has not adhered to medication advisor settings or has not taken an appropriate number of blood sugar measurements within a given time period.

鉴于以上,保健提供者可以向患者发送警报或消息。在一方面中,警报可以包括进行血糖测量的提醒。在另一示例中,警报可以包括执行结构化的测试的指令。作为示例,结构化的测试可以涉及“成对测试”(“TIP”)程序,其中鼓励患者聚焦于“之前和之后”测试,诸如在就餐之前和之后,在锻炼惯例之前和之后,在睡觉之前和之后等。这种类型的测试程序可以在原因和效果的意义上有所帮助并且提供确定原本可能看起来是贯穿一天“随机”的测试的模式的能力。用于确定这样的模式的适当逻辑以及用于“正常”或“范围外”数据的界限和边界可以编程在所推荐的规则集合40中,如图5中所示并且如以上所讨论的那样。一旦结构化的测试完成并且数据被上传到web门户并且可选地由糖尿病管理系统分析和评估,保健提供者可以被通知测试完成。In light of the above, a healthcare provider can send an alert or message to the patient. In one aspect, the alert can include a reminder to take a blood glucose measurement. In another example, the alert can include instructions to perform a structured test. As an example, structured testing can involve a "Testing in Pairs" ("TIP") program, in which the patient is encouraged to focus on "before and after" testing, such as before and after a meal, before and after an exercise routine, before and after sleep, etc. This type of testing program can help in the sense of cause and effect and provide the ability to identify patterns in what might otherwise appear to be "random" testing throughout the day. Appropriate logic for determining such patterns, as well as the limits and boundaries for "normal" or "out-of-range" data, can be programmed into the recommended rule set 40, as shown in FIG5 and discussed above. Once the structured test is completed and the data is uploaded to a web portal and optionally analyzed and evaluated by the diabetes management system, the healthcare provider can be notified of the test completion.

在一个示例中,保健提供者能够考查相关医学和使用数据和统计量,最终查明患者在早餐之后具有过高测量。在与患者的最后一次约会时,保健提供者由于早餐之后的高血糖而调节针对早餐的胰岛素:碳水化合物比以便更激进。保健提供者现在可以看到调节可能过于激进,并且提供发送到诸如用药建议器之类的便携式医学设备的较不激进的设置,并且向患者发送警报或消息以执行针对一周内的早餐就餐的另外的TIP。一旦TIP完成并且数据被上传到web门户,可以向保健提供者提供通知。保健提供者然后可以考查结果得到的数据和糖尿病管理应用累积和/或评估的任何统计量以便查明是否已经解决问题。In one example, a healthcare provider can review relevant medical and usage data and statistics and ultimately determine that the patient has excessive blood sugar after breakfast. During their last appointment with the patient, the healthcare provider adjusted the insulin: carbohydrate ratio for breakfast to be more aggressive due to the high blood sugar after breakfast. The healthcare provider can now see that the adjustment may be too aggressive and provides a less aggressive setting sent to a portable medical device such as a medication advisor, and sends an alert or message to the patient to perform another TIP for breakfast meals within a week. Once the TIP is completed and the data is uploaded to the web portal, a notification can be provided to the healthcare provider. The healthcare provider can then review the resulting data and any statistics accumulated and/or evaluated by the diabetes management application to determine whether the problem has been resolved.

示例2Example 2

保健提供者过滤与web门户上的保健提供者账户相关联的所有患者数据以便标识具有指示大于7.5%的过去三个月内的血液糖分(葡萄糖)的平均水平(HbA1c)的任何实验室测试数据的所有患者。对于许多患者,目标可能是保持该水平处于或低于6.5-7%。对于具有增加的水平的患者,web门户中的数据可以被进一步过滤以确定哪些患者在过去三个月内尚未具有与保健提供者的约会。该数据可以使用web门户手动获取,或者糖尿病管理系统可以配置成为保健提供者提供那些患者的列表,并且保健提供者可以向每一个患者发送警报或消息以联系他们安排接下来的约会。在某些方面中,糖尿病管理系统可以配置成在预确定的时间和/或间隔自动运行这样的查询。The healthcare provider filters all patient data associated with the healthcare provider's account on the web portal to identify all patients with any laboratory test data indicating an average blood sugar (glucose) level (HbA1c) greater than 7.5% over the past three months. For many patients, the goal may be to maintain this level at or below 6.5-7%. For patients with increased levels, the data in the web portal can be further filtered to determine which patients have not had an appointment with the healthcare provider in the past three months. This data can be manually obtained using the web portal, or the diabetes management system can be configured to provide the healthcare provider with a list of those patients, and the healthcare provider can send an alert or message to each patient to contact them to schedule an upcoming appointment. In some aspects, the diabetes management system can be configured to automatically run such queries at predetermined times and/or intervals.

示例3Example 3

保健提供者最近对患者做出疗法改变并且添加GLP-1(胰高血糖素样肽1兴奋剂)以帮助控制餐后葡萄糖值。患者可以通过web门户或糖尿病管理应用而被提供执行针对一天中最成问题的就餐(早餐)的餐前和餐后测试的指令。保健提供者在接下来的几天可以使用web门户来检查患者的医学和使用数据。在一个示例中,累积的统计量指示患者仍旧具有高早餐后葡萄糖值。在某些方面中,这可以通过糖尿病管理应用将使用和医学数据与所推荐的规则集合中的值比较并且注释任何范围外数据来发现。保健提供者可以通过经由web门户接收警报来被通知该情形,或者保健提供者可以考查便携式医学设备上传的数据。响应于高葡萄糖值,保健提供者可以向患者发送警报或消息以增加其胰岛素计量,并且继续检查餐前和餐后早餐葡萄糖。保健提供者可以在另外的几天后继续检查门户,并且可以看到患者的早餐后值现在处于正常范围或目标内。保健提供者可以通过web门户向患者发送跟进警报、消息或笔记以通知患者修正的剂量正确,并且如果患者在下一次办公室拜访之前具有任何问题则进行跟进。A healthcare provider recently changed a patient's therapy and added a GLP-1 (glucagon-like peptide 1 agonist) to help control post-meal glucose values. The patient may be provided instructions, via a web portal or diabetes management application, to perform pre- and post-meal testing for the most problematic meal of the day (breakfast). The healthcare provider may use the web portal to review the patient's medical and usage data over the following days. In one example, accumulated statistics indicate that the patient still has high post-breakfast glucose values. In certain aspects, this can be discovered by the diabetes management application comparing usage and medical data with values in a recommended rule set and noting any out-of-range data. The healthcare provider may be notified of this situation by receiving an alert via the web portal, or by reviewing data uploaded by a portable medical device. In response to the high glucose value, the healthcare provider may send an alert or message to the patient to increase their insulin dosage and continue to check pre- and post-breakfast glucose. The healthcare provider may continue to review the portal over the next few days and see that the patient's post-breakfast value is now within the normal range or target. The healthcare provider may send a follow-up alert, message, or note to the patient through the web portal to inform the patient that the revised dosage is correct and to follow up if the patient has any questions before the next office visit.

已经出于说明和描述的目的而提供了实施例和示例的前述描述。其不意图是详尽的或者限制本公开。特定实施例的各个元件或特征一般不限于该特定实施例,而是在适用的情况下可互换并且可以使用在所选实施例中,即使并未具体示出或描述。这还可以以许多方式变化。这样的变化不被视为脱离于本公开,并且所有这样的修改意图包括在本公开的范围内。The foregoing description of the embodiments and examples has been provided for the purpose of illustration and description. It is not intended to be exhaustive or to limit the present disclosure. The individual elements or features of a particular embodiment are generally not limited to that particular embodiment, but are interchangeable where applicable and can be used in selected embodiments, even if not specifically shown or described. This can also be varied in many ways. Such variations are not to be considered as departing from the present disclosure, and all such modifications are intended to be included within the scope of the present disclosure.

Claims (17)

1.一种用于监视多次皮下注射胰岛素治疗的糖尿病管理系统(10,10’,30,30’),包括:1. A diabetes management system (10, 10', 30, 30') for monitoring multiple subcutaneous insulin injections, comprising: - 与患者相关联的便携式医学设备(28);- Portable medical devices associated with patients (28); - 由患者和保健提供者二者可访问的数据储存库(26);- A data repository accessible to both patients and healthcare providers (26); - 糖尿病管理应用(33),其被配置用于从便携式医学设备接收数据并且将其存储在数据储存库中,数据包括与患者相关联的医学数据和与患者对便携式医学设备的使用相关联的使用数据,其中使用数据包括指示患者对用药治疗建议的依循性的数据,所述指示患者的依循性的数据包括以下中的一个或多个:- A diabetes management application (33) configured to receive data from a portable medical device and store it in a data repository, the data including medical data associated with the patient and usage data associated with the patient's use of the portable medical device, wherein the usage data includes data indicative of the patient's adherence to medication recommendations, the data indicative of the patient's adherence including one or more of the following: ○在指定周期期间进行的血糖测量的数目和计时;○ The number and timing of blood glucose measurements taken during the specified period; ○所派给的用药治疗的数目、量和计时;○ The number, dosage, and timing of the prescribed medication treatments; ○所派给的校正治疗的数目、量和计时;○ The number, amount, and duration of corrective treatments assigned; 其中糖尿病管理系统被配置用于收集指示医学数据或使用数据与存储在数据储存库中的数据同步的次数的统计数据并且用于显示所指示的次数;The diabetes management system is configured to collect statistics on the number of times medical data or usage data is synchronized with data stored in a data repository and to display the indicated number of times. 其中糖尿病管理应用被配置成:累积和评估涉及使用数据的统计量,包括累积自新疗法调节开始起患者的一定数目的过低或过高血糖测量以及将自新疗法调节开始起患者的过低或过高血糖测量的数目与最大接受值进行比较;并且当统计量满足或超过预确定的治疗准则时向患者或保健提供者提供治疗推荐,包括当自新疗法调节开始起患者的过低或过高血糖测量的数目大于最大接受值时向患者或保健提供者提供治疗推荐。The diabetes management application is configured to: accumulate and evaluate statistics related to the data used, including accumulating a certain number of hypoglycemic or hyperglycemic measurements of patients since the start of therapy-reduction and comparing the number of hypoglycemic or hyperglycemic measurements of patients since the start of therapy-reduction with the maximum acceptable value; and provide treatment recommendations to patients or healthcare providers when the statistics meet or exceed predetermined treatment guidelines, including providing treatment recommendations to patients or healthcare providers when the number of hypoglycemic or hyperglycemic measurements of patients since the start of therapy-reduction is greater than the maximum acceptable value. 2.权利要求1的糖尿病管理系统,还包括:2. The diabetes management system of claim 1 further includes: - 设备转移组件(32),其中设备转移组件安装在经由网络(16)连接到一个或多个服务器的患者计算设备(20)上,其中设备转移组件使得患者计算设备能够从便携式医学设备向安装在一个或多个服务器上的糖尿病管理应用(33)发送数据,由此设备转移组件被配置成经由网络向一个或多个服务器发送所述数据并且在已经成功发送所述数据之后从设备转移组件和/或从患者计算设备(20)立即擦除数据的任何副本。- Device transfer component (32), wherein the device transfer component is installed on a patient computing device (20) connected to one or more servers via a network (16), wherein the device transfer component enables the patient computing device to send data from a portable medical device to a diabetes management application (33) installed on one or more servers, thereby configuring the device transfer component to send the data to one or more servers via the network and to immediately erase any copies of the data from the device transfer component and/or from the patient computing device (20) after the data has been successfully sent. 3.权利要求2的糖尿病管理系统,其中经由设备转移组件发送的数据包括对所述数据从其接收的便携式医学设备(28)唯一的标识符代码;其中一个或多个服务器被配置成执行包括以下的步骤:3. The diabetes management system of claim 2, wherein the data transmitted via the device transfer component includes a unique identifier code for the portable medical device (28) from which the data is received; wherein one or more servers are configured to perform steps including: - 从设备转移组件接收具有标识符代码的数据;- Receive data with identifier codes from the device transfer component; - 评估所述标识符代码是否已经与所述患者在糖尿病管理应用(33)中的账户相关联地存储,其中所述存储指示由所述标识符代码标识的便携式医学设备针对所述患者的成功注册;- Assess whether the identifier code has been stored in association with the patient’s account in the diabetes management application (33), wherein the storage indicates successful registration of the portable medical device identified by the identifier code for the patient; - 如果所述标识符代码已经与所述患者的账户相关联地存储,将所接收的数据自动存储在数据储存库中的所述患者的账户中,从而将标识符代码用作患者的唯一必要的验证数据并且经由所述标识符代码在糖尿病管理应用处自动验证患者;- If the identifier code is already stored in association with the patient's account, the received data is automatically stored in the patient's account in the data store, thereby using the identifier code as the only necessary verification data for the patient and automatically verifying the patient at the diabetes management application via the identifier code; - 如果所述标识符代码尚未与所述患者的账户相关联地存储,经由用户接口提示患者录入验证数据;评估所录入的验证数据;仅在成功验证的情况下,将所接收的数据自动存储在数据储存库中的所述患者的账户中,从而与患者的账户相关联地存储标识符代码并且在糖尿病管理应用处自动注册所述便携式医学设备。- If the identifier code is not already stored in association with the patient's account, prompt the patient to enter verification data via the user interface; evaluate the entered verification data; and only if the verification is successful, automatically store the received data in the patient's account in the data store, thereby storing the identifier code in association with the patient's account and automatically registering the portable medical device in the diabetes management application. 4.根据前述权利要求1-3中任一个的糖尿病管理系统,其中糖尿病管理应用被配置成基于治疗推荐远程调节便携式医学设备上的至少一个设备设置。4. A diabetes management system according to any one of claims 1-3, wherein the diabetes management application is configured to remotely adjust at least one device setting on a portable medical device based on treatment recommendations. 5.根据前述权利要求1-3中任一个的糖尿病管理系统,还包括一个或多个服务器(18),其被配置成共享信息并且管理具有医学条件的患者的诊断和治疗,一个或多个服务器被配置成施行包括以下的步骤:5. The diabetes management system according to any one of claims 1-3 further includes one or more servers (18) configured to share information and manage the diagnosis and treatment of patients with medical conditions, the one or more servers being configured to perform the following steps: - 提供患者和保健提供者二者可访问的web门户账户,其中web门户账户与便携式医学设备(28)相关联;- Provides a web portal account accessible to both patients and healthcare providers, wherein the web portal account is associated with a portable medical device (28); - 从便携式医学设备接收(130)医学数据和使用数据,医学数据与患者相关联并且使用数据指示患者对便携式医学设备的使用;- Receive (130) medical data and usage data from the portable medical device, the medical data being associated with the patient and the usage data indicating the patient’s use of the portable medical device; - 累积(140)涉及使用数据的统计量,其中统计量在一段时间内累积并且在web门户账户中可访问;- Cumulative (140) refers to statistics on the use of data, where the statistics are accumulated over a period of time and are accessible in the web portal account; - 与治疗准则有关地评估(150)统计量;以及- Assess (150) statistics in relation to treatment guidelines; and - 当至少一个统计量满足或超过治疗准则时向患者或保健提供者发送(170)治疗推荐。- Send a (170) treatment recommendation to the patient or healthcare provider when at least one statistic meets or exceeds the treatment criteria. 6.根据权利要求5的糖尿病管理系统,其中统计量指示血糖测量、碳水化合物消耗、用药治疗、基础率和对治疗推荐的依循性中的至少一个。6. The diabetes management system of claim 5, wherein the statistics indicate at least one of blood glucose measurement, carbohydrate consumption, medication treatment, basal rate, and adherence to treatment recommendations. 7.根据权利要求5的糖尿病管理系统,其中一个或多个服务器还被配置用于从与患者相关联的多个便携式医学设备累积统计量。7. The diabetes management system of claim 5, wherein one or more servers are further configured to accumulate statistics from multiple portable medical devices associated with the patient. 8.根据权利要求5的糖尿病管理系统,其中一个或多个服务器还被配置用于向保健提供者提供一个或多个所提出的治疗推荐,从而使得保健提供者能够选择至少一个所提出的治疗推荐并且将所选治疗推荐发送到患者计算设备(20)。8. The diabetes management system of claim 5, wherein one or more servers are further configured to provide one or more proposed treatment recommendations to a healthcare provider, thereby enabling the healthcare provider to select at least one proposed treatment recommendation and send the selected treatment recommendation to a patient computing device (20). 9.根据权利要求5的糖尿病管理系统,其中治疗推荐包括关于饮食习惯的提醒、从便携式医学设备向web门户账户转移数据的提醒、测试血糖水平的提醒、校正基础率改变推荐和校正用药剂量推荐中的至少一个。9. The diabetes management system of claim 5, wherein treatment recommendations include at least one of reminders regarding dietary habits, reminders for transferring data from a portable medical device to a web portal account, reminders for testing blood glucose levels, recommendations for correcting basal rate changes, and recommendations for correcting medication dosage. 10.根据权利要求5的糖尿病管理系统,其中与web门户账户相关联的数据经由便携式医学设备可访问。10. The diabetes management system of claim 5, wherein the data associated with the web portal account is accessible via a portable medical device. 11.根据前述权利要求1-3中任一个的糖尿病管理系统,还包括一个或多个服务器(18),其被配置成管理患者的多次皮下注射胰岛素疗程,一个或多个服务器被配置成施行包括以下的步骤:11. The diabetes management system according to any one of claims 1-3 further includes one or more servers (18) configured to manage multiple subcutaneous insulin injection courses for a patient, the one or more servers being configured to perform the following steps: - 提供患者和保健提供者二者可访问的web门户账户,其中web门户账户与便携式医学设备(28)相关联;- Provides a web portal account accessible to both patients and healthcare providers, wherein the web portal account is associated with a portable medical device (28); - 从便携式医学设备接收(130)医学数据和使用数据,医学数据与患者相关联并且使用数据指示患者对便携式医学设备的使用;- Receive (130) medical data and usage data from the portable medical device, the medical data being associated with the patient and the usage data indicating the patient’s use of the portable medical device; - 累积(140)涉及使用数据的统计量,其中统计量在一段时间内累积并且在web门户账户中可访问;- Cumulative (140) refers to statistics on the use of data, where the statistics are accumulated over a period of time and are accessible in the web portal account; - 与治疗准则有关地评估(150)统计量;- Assessment of (150) statistics in relation to treatment guidelines; - 将统计量与web门户账户相关联(160)以供患者和保健提供者中的一个或二者访问;以及- Associate statistics with a web portal account (160) for access by one or both of the patient and the healthcare provider; and - 当至少一个统计量满足或超过预确定的治疗准则时向患者或保健提供者提供治疗推荐。- Provide treatment recommendations to patients or healthcare providers when at least one statistic meets or exceeds predetermined treatment criteria. 12.根据前述权利要求1-3中任一个的糖尿病管理系统,其中治疗推荐包括患者的胰岛素:碳水化合物比的调节。12. A diabetes management system according to any one of claims 1-3, wherein treatment recommendations include adjustment of the patient's insulin:carbohydrate ratio. 13.根据权利要求5的糖尿病管理系统,其中一个或多个服务器还被配置用于向便携式医学设备发送作为电子消息的治疗推荐。13. The diabetes management system of claim 5, wherein one or more servers are further configured to send treatment recommendations as electronic messages to portable medical devices. 14.根据权利要求13的糖尿病管理系统,其中一个或多个服务器还被配置用于在向患者计算设备(20)发送治疗推荐之前征求来自保健提供者的输入。14. The diabetes management system of claim 13, wherein one or more servers are further configured to solicit input from a healthcare provider before sending treatment recommendations to the patient's computing device (20). 15.根据权利要求5的糖尿病管理系统,其中一个或多个服务器还被配置用于基于治疗推荐远程调节便携式医学设备(28)上的至少一个设备设置。15. The diabetes management system of claim 5, wherein one or more servers are further configured to remotely adjust at least one device setting on a portable medical device (28) based on treatment recommendations. 16.根据权利要求15的糖尿病管理系统,其中设备设置包括胰岛素:碳水化合物比、基础率、最大用药量、校准设置、实用程序设置和警报设置中的至少一个。16. The diabetes management system of claim 15, wherein the device settings include at least one of insulin: carbohydrate ratio, basal rate, maximum dosage, calibration settings, utility settings, and alarm settings. 17.根据权利要求5的糖尿病管理系统,其中一个或多个服务器被配置成使得保健提供者能够选择用于评估的统计量的类型。17. The diabetes management system of claim 5, wherein one or more servers are configured to enable healthcare providers to select the type of statistics used for assessment.
HK16109332.0A 2013-04-26 2014-04-25 Diabetes management system with a medical device HK1221137B (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201361816659P 2013-04-26 2013-04-26
US201361816642P 2013-04-26 2013-04-26
US61/816659 2013-04-26
US61/816642 2013-04-26
US14/245,180 US20140324445A1 (en) 2013-04-26 2014-04-04 Diabetes management system medical device usage statistics
US14/245180 2014-04-04
PCT/EP2014/058426 WO2014174063A1 (en) 2013-04-26 2014-04-25 Diabetes management system with a medical device

Publications (2)

Publication Number Publication Date
HK1221137A1 HK1221137A1 (en) 2017-05-26
HK1221137B true HK1221137B (en) 2019-12-20

Family

ID=

Similar Documents

Publication Publication Date Title
EP2988671B1 (en) Diabetes management system with a medical device
Petrie et al. Improving the clinical value and utility of CGM systems: issues and recommendations: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group
US20230329556A1 (en) Subcutaneous outpatient management
Shrivastav et al. Type 2 diabetes management in primary care: the role of retrospective, professional continuous glucose monitoring
US9330237B2 (en) Pattern recognition and filtering in a therapy management system
JP7177911B2 (en) Systems and methods for remote prescription of drug administration regimens
CA2745169C (en) Diabetes therapy management system
US20100161346A1 (en) Systems and Methods for Providing Bolus Dosage Recommendations
US20100160740A1 (en) Use of Patterns in a Therapy Management System
EP2654564B1 (en) Calibration of a handheld diabetes managing device that receives data from a continuous glucose monitor
US20080071580A1 (en) System and method for medical evaluation and monitoring
US20090150186A1 (en) Flexible glucose analysis using varying time report deltas and configurable glucose target ranges
US20070033074A1 (en) Therapy management system
US20240120051A1 (en) System and Method for Patient Care Improvement
US20110077956A1 (en) Systems For Treatment-Related Product Promotion And Ordering Via A Medical Measurement Device
WO2024108019A1 (en) Tracking, reporting, and visualizing pregnancy-related analyte data
US20110077967A1 (en) Systems For Procuring Regulatory Data From A Patient Via A Medical Measurement Device
CN113270162A (en) Intelligent perfecting, auditing and quality control method based on health file
US20110077492A1 (en) Systems for Bidirectional Communication With A Patient Via A Medical Measurement Device
CN112655045A (en) Method for detecting basal rate problems in insulin-treated diabetic patients
HK1221137B (en) Diabetes management system with a medical device
Larned et al. Ochsner Chemotherapy Care Companion: Improving Outcomes Through Digital Medicine
CA2938541A1 (en) Diabetes therapy management system
TA Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations
HK40049742A (en) Method for detecting issues in the basal rate in insulin treated diabetes patients